Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 1.950
-0.090 (-4.41%)
Aug 28, 2025, 3:59 PM AEST
Artrya Market Cap
Artrya has a market cap or net worth of 229.40 million as of August 28, 2025. Its market cap has increased by 979.51% in one year.
Market Cap
229.40M
Enterprise Value
218.69M
Revenue
28.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.95
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 229.40M, an increase of 92.57%. That is a compound annual growth rate of 19.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 239.98M | 394.97% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 104.78B |
| Pro Medicus | 31.71B |
| Cochlear | 19.69B |
| Sonic Healthcare | 11.78B |
| Ramsay Health Care | 8.85B |
| Telix Pharmaceuticals | 6.41B |
| Ansell | 4.99B |
| Mesoblast | 3.13B |